The EGF+GHRP6 combined therapy for stroke was designed to activate a cascade of endogenous neuroprotection mechanisms, including regeneration of adult neural stem cells and repair in the penumbra zone (26–31, 57, 71, 72). The gene discussed is EGF; the disease is stroke disorder.